相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma
Hongqing Zhuang et al.
ONCOTARGET (2016)
Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair
Corina Penterling et al.
PLOS ONE (2016)
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
P. M. Ellis et al.
CURRENT ONCOLOGY (2015)
Survival Fraction at 2 Gy and γH2AX Expression Kinetics in Peripheral Blood Lymphocytes From Cancer Patients: Relationship With Acute Radiation-Induced Toxicities
Stamatia E. Pouliliou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
DNA repair mechanisms in cancer development and therapy
Alessandro Torgovnick et al.
FRONTIERS IN GENETICS (2015)
Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study
Xiaofeng Chen et al.
PLOS ONE (2014)
Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer
Henning Willers et al.
CANCER JOURNAL (2013)
Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies
Fenlai Tan et al.
LUNG CANCER (2012)
Combined Treatment of Nonsmall Cell Lung Cancer NSCLC Stage III With Intensity-Modulated RT Radiotherapy and Cetuximab
Alexandra D. Jensen et al.
CANCER (2011)
Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small-Cell Lung Cancer: RTOG 0324
George R. Blumenschein et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective
Marcel Verheij et al.
DRUG RESISTANCE UPDATES (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiosensitizing effects of gefitinib at different administration times in vitro
Hong-Qing Zhuang et al.
CANCER SCIENCE (2009)
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
Y. Akashi et al.
BRITISH JOURNAL OF CANCER (2008)
DNA damage repair and response proteins as targets for cancer therapy
Howard B. Lieberman
CURRENT MEDICINAL CHEMISTRY (2008)
The epidermal growth factor receptor: A role in repair of radiation-induced DNA damage
David J. Chen et al.
CLINICAL CANCER RESEARCH (2007)
Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiorsensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair
Mahmoud Toulany et al.
CLINICAL CANCER RESEARCH (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells
JN Contessa et al.
ONCOGENE (2002)
分享论文
